BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19766676)

  • 1. Long-term consequences of a single treatment of mice with an ultra-low dose of Delta9-tetrahydrocannabinol (THC).
    Amal H; Fridman-Rozevich L; Senn R; Strelnikov A; Gafni M; Keren O; Sarne Y
    Behav Brain Res; 2010 Jan; 206(2):245-53. PubMed ID: 19766676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage.
    Assaf F; Fishbein M; Gafni M; Keren O; Sarne Y
    Behav Brain Res; 2011 Jun; 220(1):194-201. PubMed ID: 21315768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in the effects of delta9-tetrahydrocannabinol on spatial learning in adolescent and adult rats.
    Cha YM; Jones KH; Kuhn CM; Wilson WA; Swartzwelder HS
    Behav Pharmacol; 2007 Sep; 18(5-6):563-9. PubMed ID: 17762524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single low dose of tetrahydrocannabinol induces long-term cognitive deficits.
    Tselnicker I; Keren O; Hefetz A; Pick CG; Sarne Y
    Neurosci Lett; 2007 Jan; 411(2):108-11. PubMed ID: 17092651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with Delta(9)-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain.
    Boucher AA; Vivier L; Metna-Laurent M; Brayda-Bruno L; Mons N; Arnold JC; Micheau J
    Behav Pharmacol; 2009 Feb; 20(1):45-55. PubMed ID: 19179850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
    Jardinaud F; Roques BP; Noble F
    Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term cognitive deficits induced by a single, extremely low dose of tetrahydrocannabinol (THC): behavioral, pharmacological and biochemical studies in mice.
    Senn R; Keren O; Hefetz A; Sarne Y
    Pharmacol Biochem Behav; 2008 Jan; 88(3):230-7. PubMed ID: 17888506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Despite strong behavioral disruption, Delta9-tetrahydrocannabinol does not affect cell proliferation in the adult mouse dentate gyrus.
    Kochman LJ; dos Santos AA; Fornal CA; Jacobs BL
    Brain Res; 2006 Oct; 1113(1):86-93. PubMed ID: 16930565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of delta9-THC on learning in adolescent and adult rats.
    Cha YM; White AM; Kuhn CM; Wilson WA; Swartzwelder HS
    Pharmacol Biochem Behav; 2006 Mar; 83(3):448-55. PubMed ID: 16631921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol.
    Beraki S; Kuzmin A; Tai F; Ogren SO
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):486-97. PubMed ID: 18242064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
    Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
    J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.
    D'Souza DC; Abi-Saab WM; Madonick S; Forselius-Bielen K; Doersch A; Braley G; Gueorguieva R; Cooper TB; Krystal JH
    Biol Psychiatry; 2005 Mar; 57(6):594-608. PubMed ID: 15780846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine-like behavioral effects following withdrawal from chronic delta-9-tetrahydrocannabinol administration in rats.
    Holson RR; Ali SF; Scallet AC; Slikker W; Paule MG
    Neurotoxicology; 1989; 10(3):605-19. PubMed ID: 2576305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ultra-low dose of tetrahydrocannabinol provides cardioprotection.
    Waldman M; Hochhauser E; Fishbein M; Aravot D; Shainberg A; Sarne Y
    Biochem Pharmacol; 2013 Jun; 85(11):1626-33. PubMed ID: 23537701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
    Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
    Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion.
    Gorriti MA; Ferrer B; del Arco I; Bermúdez-Silva FJ; de Diego Y; Fernandez-Espejo E; Navarro M; Rodríguez de Fonseca F
    Pharmacol Biochem Behav; 2005 May; 81(1):71-7. PubMed ID: 15894066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.
    Célérier E; Ahdepil T; Wikander H; Berrendero F; Nyberg F; Maldonado R
    Neuropharmacology; 2006 Jun; 50(7):788-806. PubMed ID: 16443242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance.
    Müller-Vahl KR; Koblenz A; Jöbges M; Kolbe H; Emrich HM; Schneider U
    Pharmacopsychiatry; 2001 Jan; 34(1):19-24. PubMed ID: 11229617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor effects of delta 9 THC in cerebellar Lurcher mutant mice.
    Lorivel T; Hilber P
    Behav Brain Res; 2007 Aug; 181(2):248-53. PubMed ID: 17531329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.